Life Sciences BPO Market Research, Global Analysis, Industry Demand and Forecast 2018-2026

1. Life Sciences BPO Market - Size, Share, Life Sciences BPO Market - Size, Share, Growth, Outlook, and Opportunity Analysis, Growth, Outlook, and Opportunity Analysis, 2018-2026 2018-2026 Life science business process outsourcing (BPO) is one of the most lucrative industries in the healthcare sector. Constantly rising pricing pressure and increasing competition is compelling pharmaceutical and medical device companies to strategically reduce their operational costs and in turn benefit from higher profits. This has led to an increasing demand for contract manufacturing outsourcing (CMO) and contract research outsourcing (CRO) services. Asia and Latin America are the most attractive markets for CMO and CRO, owing to low costs of production and research activities performed here. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/24 The global life sciences BPO market is driven by factors such as increasing cost of research and development (R&D), growing price pressures, and increase in investments by pharmaceutical and medical devices companies in emerging economies such as India, China, Brazil, and South Africa. Pharmaceutical and medical device companies are adopting inorganic growth strategies to expand their business and reduce their Capital Expenditure (CAPEX) and Operation Costs (OPEX). However, outsourcing certain services to different CMO and CRO companies located in other countries is a challenge for the outsourcing company to monitor and follow a particular set of guideline for product approval pertaining to regulatory filings, clinical trials and medical writing. Collaborative efforts among various stakeholders of the ecosystem is analyzed to benefit the life science BPO industry in the long run. Patent expirations to boost the prospects for life sciences BPO market According to UBM India Pharma Publication, over US$ 40 billion worth of drug are expected to be off-patent in the U.S. by 2017. Also, in 2014, utilization of generic drugs resulted in savings of around US$ 254 billion in the U.S. This trend is anticipated to increase further with more patent

2. expirations in the near future. This factor coupled with the advent of biosimilars is projected to favor the growth of life sciences BPO market over the forecast period. Report includes chapters which deeply display the following deliverable about industry : • Life Sciences BPO Market Research Objective and Assumption • Life Sciences BPO Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Life Sciences BPO Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Life Sciences BPO Market, By Regions • Life Sciences BPO Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Life Sciences BPO Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Life Sciences BPO Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Life Sciences BPO Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key companies covered as a part of this study include Anthelio Healthcare Solutions, Accenture plc, Cognizant Technology Solutions, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation and Quintiles Transnational Corporation. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/24 Detailed Segmentation:

3. Global Life Sciences BPO Market, By Service Type: • Medical Device Outsourcing • Pharmaceutical Outsourcing  CMO  API Manufacturing  Final dosage form manufacturing  Packaging  CRO  Drug Discovery  Preclinical studies  Early Phase I - IIa  Phase IIa - III  Phase IIIb - IV  Medical coding and writing  Monitoring  Clinical Data Management  Bio-statistics  Site management  Protocol development • Regulatory Information Global Life Sciences BPO Market, By End User: • Healthcare Providers • Healthcare Payers Global Life Sciences BPO Market, By Geography: • North America • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200

4. Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com